PBM
Propel Bio Management’s TScan Therapeutics TCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03M | Hold |
2,087,139
| – | – | 3.67% | 9 |
|
|
2025
Q1 | $2.88M | Hold |
2,087,139
| – | – | 3.35% | 9 |
|
|
2024
Q4 | $6.34M | Hold |
2,087,139
| – | – | 6.3% | 7 |
|
|
2024
Q3 | $10.4M | Hold |
2,087,139
| – | – | 6.03% | 5 |
|
|
2024
Q2 | $12.2M | Hold |
2,087,139
| – | – | 7.92% | 3 |
|
|
2024
Q1 | $16.6M | Hold |
2,087,139
| – | – | 9.65% | 3 |
|
|
2023
Q4 | $12.2M | Buy |
+2,087,139
| New | +$12.2M | 10.09% | 3 |
|